Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2019 Oct 3.

Published in final edited form as: Diabet Med. 2019 Jul 7;36(9):1075–1081. doi: 10.1111/dme.14050

Percentage of cases presenting with new-onset Type 1 diabetes stratified by duration from initial anti-programmed cell death protein-1 (PD-1)or anti-programmed cell death protein-1 ligand (PD-L1) exposure. (a) Graph showing that 71% of the cases developed Type 1 diabetes in the first 3 months; n=65 cases reporting time to diabetes onset. (b) Duration to diabetes onset by treatment agent.

Percentage of cases presenting with new-onset Type 1 diabetes stratified by duration from initial anti-programmed cell death protein-1 (PD-1)or anti-programmed cell death protein-1 ligand (PD-L1) exposure. (a) Graph showing that 71% of the cases developed Type 1 diabetes in the first 3 months; n=65 cases reporting time to diabetes onset. (b) Duration to diabetes onset by treatment agent.